Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 09, 2025

Get In Touch

Adding Vein Of Marshall Ethanol Infusion To Catheter Ablation Improves AF Outcomes: JAMA Surgery

Adding Vein Of Marshall Ethanol Infusion To Catheter Ablation Improves AF Outcomes: JAMA

  • 23 July 2025
  • 3 months ago

Early Surgery For Acute Active Infective Endocarditis Feasible Soon After Stroke, Claims Study Surgery

Early Surgery For Acute Active Infective Endocarditis Feasible Soon After Stroke, Claims Study

  • 23 July 2025
  • 3 months ago

SGLT2 Inhibitors With Conventional Diuretics Lower All-Cause Mortality In HF Patients Cardiology and CTVS

SGLT2 Inhibitors With Conventional Diuretics Lower All-Cause Mortality In HF Patients

  • 23 July 2025
  • 3 months ago

Personalized Patient Visualization Of CAC Imaging With Statin Therapy Tied To Reduced CV Risk Cardiology and CTVS

Personalized Patient Visualization Of CAC Imaging With Statin Therapy Tied To Reduced CV Risk

  • 23 July 2025
  • 3 months ago

Deferred PCI Equally Safe Whether Treatment Decision Based On IVUS Or FFR: Study Cardiology and CTVS

Deferred PCI Equally Safe Whether Treatment Decision Based On IVUS Or FFR: Study

  • 23 July 2025
  • 3 months ago

2021 ESC Guideline On Valvular Heart Diseases: Single Antiplatelet Recommended Post TAVI And More. Cardiology and CTVS

2021 ESC Guideline On Valvular Heart Diseases: Single Antiplatelet Recommended Post TAVI And More.

  • 23 July 2025
  • 3 months ago

Zerlasiran May Prevent Heart Disease By Lowering Lipoprotein(A) Concentrations: JAMA Cardiology and CTVS

Zerlasiran May Prevent Heart Disease By Lowering Lipoprotein(A) Concentrations: JAMA

  • 23 July 2025
  • 3 months ago

USFDA Approves Alembic Pharma Five Products In Over A Month Cardiology and CTVS

USFDA Approves Alembic Pharma Five Products In Over A Month

  • 23 July 2025
  • 3 months ago

Pitavastatin Promising For Reducing Risk Of Cardiovascular Disease In People With HIV: REPRIEVE Substudy Cardiology and CTVS

Pitavastatin Promising For Reducing Risk Of Cardiovascular Disease In People With HIV: REPRIEVE Substudy

  • 23 July 2025
  • 3 months ago

Maternal Grief In The Third Trimester Tied To Increased Risk Of Ischemic Heart Disease In Offspring: JAMA Obstetrics and Gynaecology

Maternal Grief In The Third Trimester Tied To Increased Risk Of Ischemic Heart Disease In Offspring: JAMA

  • 23 July 2025
  • 3 months ago

Recent News

Mankind Pharma net profit declines 21 percent to R...

  • 09 November, 2025

Kerala waives Rs 10 lakh discontinuation penalty f...

  • 09 November, 2025

Jharkhand health dept announces SOP for ICU and CC...

  • 09 November, 2025

Doctors oppose Punjab govt's decision to set up me...

  • 09 November, 2025

Biocon gets 2 USFDA observations for Visakhapatnam...

  • 09 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.